Login to Your Account



Other News To Note


Wednesday, March 16, 2011
Apeiron Biologics AG, of Vienna, Austria, and the Cleveland Clinic Foundation, of Cleveland, have agreed to collaborate on anticancer compounds currently in development at the clinic. The collaboration includes an option to Apeiron to enter a worldwide, exclusive license agreement with the clinic relating to the compounds, and an Apeiron-sponsored research agreement with the clinic relating to those compounds and approach, the company said.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription